CEACAM6 gene expression in intrahepatic cholangiocarcinoma

British Journal of Cancer

Volumn 95, Issue 4, 2006, Pages 532-540

  Ieta, K ^a,b   Tanaka, F ^a   Utsunomiya, T ^a   Kuwano, H ^b   Mori, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Carcinoembryonic antigen related cell adhesion molecule 6 (CEACAM6); Cholangiocarcinoma; Gemcitabine

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; GEMCITABINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN; MESSENGER RNA; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANOIKIS; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CEACAM6 GENE; CELL CYCLE; CELL PROLIFERATION; CHEMOSENSITIVITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SURVIVAL RATE;

ANTIGENS, CD; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL ADHESION MOLECULES; CELL DIVISION; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PROGNOSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33747171944     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603276     Document Type: Article

References (29)

1. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245
2. Blumenthal RD, Hansen HJ, Goldenberg DM (2005) Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res 65: 8809-8817
3. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004a) CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene 23: 465-473
4. Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE (2004b) Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Ann Surg 240: 667-674, discussion 675-6
5. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE (2004c) Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. Oncogene 23: 5834-5842
6. Duxbury MS, Ito H, Benoit E, Ashley SW, Whang EE (2004d) CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Br J Cancer 91: 1384-1390
7. Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE (2004e) A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res 64: 3987-3993
8. Duxbury MS, Matros E, Clancy T, Bailey G, Doff M, Zinner MJ, Ashley SW, Maitra A, Redston M, Whang EE (2005) CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions. Ann Surg 241: 491-496
9. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, Mori M (2006) Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24: 506-513
10. Hasegawa T, Isobe K, Tsuchiya Y, Oikawa S, Nakazato H, Nakashima I, Shimokata K (1993) Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer. Br J Cancer 67: 58-65
11. Ilantzis C, DeMarte L, Screaton RA, Stanners CP (2002) Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 4: 151-163
12. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, Micheel B, Brummer J, Laffer U, Metzger U, Herrmann R, Rochlitz C (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 21: 3638-3646
13. Kelley ST, Bloomston M, Serafini F, Carey LC, Karl RC, Zervos E, Goldin S, Rosemurgy P, Rosemurgy AS (2004) Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy. Am Surg 70: 743-748, discussion 748-749
14. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 1(Suppl 6): VI1-VI9
15. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366: 1303-1314
16. Kodera Y, Isobe K, Yamauchi M, Satta T, Hasegawa T, Oikawa S, Kondoh K, Akiyama S, Itoh K, Nakashima I et al (1993) Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation. Br J Cancer 68: 130-136
17. Lazaridis KN, Gores GJ (2005) Cholangiocarcinoma. Gastroenterology 128: 1655-1667
18. Mori M, Mimori K, Yoshikawa Y, Shibuta K, Utsunomiya T, Sadanaga N, Tanaka F, Matsuyama A, Inoue H, Sugimachi K (2002) Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 131: S39-47
19. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M (2005) Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 11: 2889-2893
20. Olnes MJ, Erlich R (2004) A review and update on cholangiocarcinoma. Oncology 66: 167-179
21. Ordonez C, Screaton RA, Ilantzis C, Stanners CP (2000) Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 60: 3419-3424
22. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, Thompson J (2000) Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol 156: 595-605
23. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24: 115-125
24. Shanmugathasan M, Jothy S (2000) Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 50: 273-279
25. Shibata K, Tanaka S, Shiraishi T, Kitano S, Mori M (1999) G-protein gamma 7 is down-regulated in cancers and associated with p 27kip1-induced growth arrest. Cancer Res 59: 1096-1101
26. Thompson JA, Grunert F, Zimmermann W (1991) Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 5: 344-366
27. Thongprasert S (2005) The role of chemotherapy in cholangiocarcinoma. Ann Oncol Suppl 2: ii93-ii96
28. Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H (2004) Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 95: 385-392
29. Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC, Imai K (1998) Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene 16: 2681-2686